Pharmaceutical formulations refer to the process of designing and producing medicinal products in specific dosage forms to ensure safe and effective delivery of active pharmaceutical ingredients (APIs) to patients. Formulations are tailored to meet diverse patient needs, considering factors such as route of administration, dosage strength, stability, and patient compliance. Common dosage forms include tablets, capsules, syrups, injections, creams, and patches. Formulation development involves selecting appropriate excipients, such as binders, fillers, disintegrants, and preservatives, to optimize drug delivery and stability. Techniques such as wet granulation, dry granulation, and direct compression are employed to prepare solid dosage forms, while various emulsification and dispersion methods are used for liquid formulations. Pharmaceutical formulations undergo rigorous testing and evaluation, including physicochemical characterization, stability studies, and in vitro/in vivo performance assessments, to ensure product quality, safety, and efficacy. Collaboration between formulation scientists, pharmacists, chemists, and regulatory experts is essential for developing, optimizing, and commercializing pharmaceutical formulations. Continuous advancements in formulation technology, drug delivery systems, and manufacturing processes contribute to the development of novel and improved pharmaceutical products to meet healthcare needs.
Title : Advances in plasma-based waste treatment for sustainable communities
Hossam A Gabbar, Ontario Tech University, Canada
Title : Nanostructured biodevices based on carbon nanotubes and glyconanoparticles for bioelectrocatalytic applications
Serge Cosnier, Silesian University of Technology, Poland
Title : Carbon capture and storage: The impact of impurities in CO2 streams
Andy Brown, Progressive Energy Ltd, United Kingdom
Title : Supramolecular nano chemistries: Fighting viruses, inhibiting bacteria and growing tissues
Thomas J Webster, Hebei University of Technology, China
Title : Chemical engineering of vanadium and tantalum zeolites for application in environmental catalysis
Stanislaw Dzwigaj, Sorbonne Universite, France
Title : Disrupting TNF-α and TNFR1 interaction: Computational insights into the potential of D-Pinitol as an anti-inflammatory therapeutic
Ferran Acuna Pares, Universidad Internacional de la Rioja (UNIR), Spain